Jesse Gordon
Family Medicine · Pittsburgh, PANPI 1891923595
Payments from drug & device makers
Across 243 payments — averaging $22.42 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Viiv Healthcare Company$2K
- Gilead$2K
- AbbVie$626
- Boston Scientific$192
- Johnson & Johnson$178
- Antares Pharma, Inc.$154
- plus $793 from 17 others
What the payments were for
- Travel & lodging$90%
- Food & beverage$5,40899%
- Education$311%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Viiv Healthcare Company | 93 | $1,858 |
| Gilead | 67 | $1,648 |
| AbbVie | 30 | $626 |
| Boston Scientific | 3 | $192 |
| Johnson & Johnson(2 entities) | 7 | $178 |
| Antares Pharma, Inc. | 8 | $154 |
| Exact Sciences | 2 | $131 |
| Axsome Therapeutics, Inc. | 1 | $103 |
| Merck | 5 | $102 |
| Indivior Inc. | 4 | $79 |
| Theratechnologies Inc. | 5 | $75 |
| Otsuka America Pharmaceutical, Inc. | 4 | $65 |
| Novo Nordisk | 3 | $52 |
| Janssen Products, LP | 1 | $31 |
| Alkermes, Inc. | 1 | $24 |
| Verity Pharmaceuticals Inc. | 1 | $19 |
| Halozyme Inc | 1 | $18 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $17 |
| Braeburn Inc. | 1 | $17 |
| Organon | 1 | $16 |
| Hologic Sales And Service, LLC | 1 | $16 |
| Dynavax Technologies Corporation | 2 | $14 |
| Neurocrine Biosciences, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,449 in reported general payments places this provider in the 85th percentile of 4,967 family medicine providers in Pennsylvania.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| BiktarvyBictegrav/Emtricit/Tenofov Ala | 44 | $163,919 |
| DescovyEmtricitabine/Tenofov Alafenam | 23 | $47,556 |
| TivicayDolutegravir Sodium | 12 | $24,521 |
| OzempicSemaglutide | 11 | $9,694 |
| Xtampza ErOxycodone Myristate | 12 | $3,212 |
| ProgesteroneProgesterone, Micronized | 57 | $1,538 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 15 | $1,267 |
| Estradiol | 45 | $1,177 |
| Spironolactone | 59 | $665 |
| Estradiol (Twice Weekly)Estradiol | 14 | $574 |
| Testosterone Cypionate | 11 | $495 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 13 | $368 |
| Gabapentin | 32 | $287 |
| Atorvastatin Calcium | 28 | $259 |
| Pantoprazole Sodium | 25 | $252 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GileadBiktarvy, Descovy | $1,648 | $211,47567 claims |
| Viiv Healthcare CompanyTivicay | $1,858 | $24,52112 claims |
| Novo NordiskOzempic | $52 | $9,69411 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 4,967 family medicine providers in Pennsylvania.
Other family medicine in Pittsburgh
- Bryce PalchickPittsburgh$4.7M
- Shari RozenPittsburgh$2.9M
- Nathan BennettPittsburgh$1.6M
- James MorettiPittsburgh$1.5M
- Michael GatesPittsburgh$608K
- Daniel AustinPittsburgh$598K
- Norman KolbPittsburgh$81K
- Kem YenalPhila$12.6M
- Marcy FleckerSmithfield$6.9M
- Tiffany PlutoScottdale$4.8M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.